Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Drugs in Context
|
February 22, 2024
Effect of nabiximols oromucosal spray (Sativex<sup>®</sup>) on symptoms associated with multiple sclerosis-related spasticity: a case series
Niklas Garde, Markus Heibel
Muscle & Nerve
|
May 8, 2013
Subcutaneous immunoglobulin treatment of inclusion-body myositis stabilizes dysphagia
Kaweh Pars, Niklas Garde, Thomas Skripuletz, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences
|
January 11, 2012
Visual hallucinations in Charles Bonnet syndrome can be seen in fluorodeoxyglucose-PET
Niklas Garde, Thomas Skripuletz, Refik Pul, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences
|
February 18, 2010
Bupropion-induced status epilepticus and retrograde amnesia
Thomas Skripuletz, Niklas Garde, Christian Vidal, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology
|
November 4, 2010
Glatiramer acetate modulates TNF-α and IL-10 secretion in microglia and promotes their phagocytic activity
Refik Pul, Darius Moharregh-Khiabani, Jelena Škuljec, et al.
The American Journal of Pathology
|
March 20, 2008
Cortical demyelination is prominent in the murine cuprizone model and is strain-dependent
Thomas Skripuletz, Maren Lindner, Alexandra Kotsiari, et al.
Journal of Neurology
|
August 5, 2016
Intraspinal cavernous bleeding during early pregnancy
Kaweh Pars, Niklas Garde, Josef Conzen, et al.
Plos One
|
January 4, 2013
Glatiramer acetate increases phagocytic activity of human monocytes in vitro and in multiple sclerosis patients
Refik Pul, Franco Morbiducci, Jelena Škuljec, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology
|
March 16, 2019
Botulinum neurotoxin serotype D - A potential treatment alternative for BoNT/A and B non-responding patients
Anna Kutschenko, Jasmin Weisemann, Katja Kollewe, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Drugs in Context
|
February 22, 2024
Effect of nabiximols oromucosal spray (Sativex<sup>®</sup>) on symptoms associated with multiple sclerosis-related spasticity: a case series
Niklas Garde, Markus Heibel
Muscle & Nerve
|
May 8, 2013
Subcutaneous immunoglobulin treatment of inclusion-body myositis stabilizes dysphagia
Kaweh Pars, Niklas Garde, Thomas Skripuletz, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences
|
January 11, 2012
Visual hallucinations in Charles Bonnet syndrome can be seen in fluorodeoxyglucose-PET
Niklas Garde, Thomas Skripuletz, Refik Pul, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences
|
February 18, 2010
Bupropion-induced status epilepticus and retrograde amnesia
Thomas Skripuletz, Niklas Garde, Christian Vidal, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology
|
November 4, 2010
Glatiramer acetate modulates TNF-α and IL-10 secretion in microglia and promotes their phagocytic activity
Refik Pul, Darius Moharregh-Khiabani, Jelena Škuljec, et al.
The American Journal of Pathology
|
March 20, 2008
Cortical demyelination is prominent in the murine cuprizone model and is strain-dependent
Thomas Skripuletz, Maren Lindner, Alexandra Kotsiari, et al.
Journal of Neurology
|
August 5, 2016
Intraspinal cavernous bleeding during early pregnancy
Kaweh Pars, Niklas Garde, Josef Conzen, et al.
Plos One
|
January 4, 2013
Glatiramer acetate increases phagocytic activity of human monocytes in vitro and in multiple sclerosis patients
Refik Pul, Franco Morbiducci, Jelena Škuljec, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology
|
March 16, 2019
Botulinum neurotoxin serotype D - A potential treatment alternative for BoNT/A and B non-responding patients
Anna Kutschenko, Jasmin Weisemann, Katja Kollewe, et al.
Page
of 1